RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Angie Jackson-Morris

Angie Jackson-Morris

Director, RTI Center for Noncommunicable Diseases


PhD, The University of Edinburgh
MSc, The University of Edinburgh
MA (Hons), The University of Edinburgh


Dr. Angela “Angie” Jackson-Morris leads the RTI Center for Global Noncommunicable Diseases (NCDs), providing technical leadership within the Center and overseeing technical program quality, and collaborates with partners to develop new programs of research to NCDs and wider global health challenges.

Dr. Jackson-Morris has been working to improve health across a range of countries and sectors for over twenty-five years, primarily focused on the reduction and prevention of NCDs. She has in-depth expertise in designing and guiding national strategies, policies, programs, and capacity development, supported by formative and implementation research.

Dr. Jackson-Morris developed and led the first national strategy to address NCDs for the Government of St. Helena, which won an award from the United Nations Inter-Agency Taskforce on Noncommunicable Diseases in 2020. She was Head of the global tobacco control grants program under the Bloomberg Initiative to Reduce Tobacco Use at the International Union Against TB and Lung Disease.

Previously, Dr. Jackson-Morris developed and led national strategies and programs of work on the health improvement agenda in the Republic of Maldives, India, and Scotland. She is a member of several NCD-related international advisory committees, has been a Board member/trustee of health and development organizations, and is a Fellow of the Royal Society of Public Health.